Verona Pharma reversed into cash shell Isis Resources on 19 September 2006. The reversal price was 4p. It specialises in developing treatments for respiratory ailments. The most advanced treatment is RPL554, which is aimed at hay fever and asthma sufferers. Management believes that it can cope with two or three projects at one time.